Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study
Authors
Giuseppe Pugliese (ORCID: https://orcid.org/0000-0003-1574-0397)
Antonio Nicolucci (ORCID: https://orcid.org/0000-0002-5939-6850)
Monica Vedovato
Anna Solini (ORCID: https://orcid.org/0000-0002-7855-8253)
Monia Garofolo (ORCID: https://orcid.org/0000-0002-2518-3187)
Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study
Giuseppe Pugliese, Antonio Nicolucci, Monica Vedovato, Anna Solini et al.
Citations
4 citations
Journal
Cardiovascular Diabetology
Topics
Chronic Kidney Disease and Diabetes
Field-Weighted Citation Impact (FWCI)
1.36
article
Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study
Giuseppe Pugliese, Antonio Nicolucci, Monica Vedovato, Anna Solini, Monia Garofolo, Enzo Bonora, Giuseppe Penno, Emanuela Orsi, Martina Vitale, Valeria Grancini, Roberto Trevisan, Cecilia Fondelli
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
Cardiovascular DiabetologyVol. 23(1)
Institutions
University of Siena (IT), University of Pisa (IT), University of Verona (IT), University of Padua (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Ospedale Papa Giovanni XXIII (IT), Center for Outcomes Research and Clinical Epidemiology (IT), Sapienza University of Rome (IT)
Funders
Eli Lilly and Company, Chiesi Farmaceutici, Boehringer Ingelheim, Takeda Pharmaceutical Company, Sigma-Tau Pharmaceuticals, Fondazione Diabete Ricerca